• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

COVID

  • Army scientists propose non-human primate models of COVID-19 infection.
    February 5, 2021

    Army scientists propose non-human primate models of COVID-19 infection.

    scientificinquirer
  • The Daily Dose: Toxic hard metals found in many common baby foods sold in groceries.
    February 4, 2021

    The Daily Dose: Toxic hard metals found in many common baby foods sold in groceries.

    scientificinquirer
  • Politicians must be held responsible for mishandling the COVID-19 pandemic.
    February 4, 2021

    Politicians must be held responsible for mishandling the COVID-19 pandemic.

    scientificinquirer
  • The Daily Dose: Russian vaccine shows 92% efficacy; UK variant picks up a potentially deadly mutation.
    February 2, 2021

    The Daily Dose: Russian vaccine shows 92% efficacy; UK variant picks up a potentially deadly mutation.

    scientificinquirer
  • COVID-19 kills along socio-economic lines, new study.
    February 1, 2021

    COVID-19 kills along socio-economic lines, new study.

    scientificinquirer
  • 50% vaccination rate could save 125,000 lives from COVID-19.
    January 31, 2021

    50% vaccination rate could save 125,000 lives from COVID-19.

    scientificinquirer
  • Socio-economic factors play major role in COVID-19 outcomes.
    January 31, 2021

    Socio-economic factors play major role in COVID-19 outcomes.

    scientificinquirer
  • COVID-19 leads to unexplained deaths after heart surgery.
    January 31, 2021

    COVID-19 leads to unexplained deaths after heart surgery.

    scientificinquirer
  • A third of Americans hesitant to get COVID-19 vaccine.
    January 30, 2021

    A third of Americans hesitant to get COVID-19 vaccine.

    scientificinquirer
  • Remdesivir’s mechanism against SARS-CoV-2 established.
    January 29, 2021

    Remdesivir’s mechanism against SARS-CoV-2 established.

    scientificinquirer
Previous Page
1 … 72 73 74 75 76 … 113
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Loading Comments...